- Home
- LNTH vs TMHC Comparison
LNTH vs TMHC Comparison
Compare LNTH & TMHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNTH
- TMHC
- Stock Information
- Founded
- LNTH 1956
- TMHC 1936
- Country
- LNTH United States
- TMHC United States
- Employees
- LNTH N/A
- TMHC N/A
- Industry
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- TMHC Homebuilding
- Sector
- LNTH Health Care
- TMHC Consumer Discretionary
- Exchange
- LNTH Nasdaq
- TMHC Nasdaq
- Market Cap
- LNTH 7.2B
- TMHC 7.2B
- IPO Year
- LNTH 2015
- TMHC 2013
- Fundamental
- Price
- LNTH $87.99
- TMHC $69.89
- Analyst Decision
- LNTH Strong Buy
- TMHC Buy
- Analyst Count
- LNTH 7
- TMHC 8
- Target Price
- LNTH $121.86
- TMHC $77.33
- AVG Volume (30 Days)
- LNTH 1.4M
- TMHC 866.6K
- Earning Date
- LNTH 11-06-2024
- TMHC 10-23-2024
- Dividend Yield
- LNTH N/A
- TMHC N/A
- EPS Growth
- LNTH 304.57
- TMHC N/A
- EPS
- LNTH 6.02
- TMHC 7.54
- Revenue
- LNTH $1,496,799,000.00
- TMHC $7,831,512,000.00
- Revenue This Year
- LNTH $19.56
- TMHC $6.42
- Revenue Next Year
- LNTH $6.32
- TMHC $7.33
- P/E Ratio
- LNTH $14.36
- TMHC $9.18
- Revenue Growth
- LNTH 24.15
- TMHC N/A
- 52 Week Low
- LNTH $50.20
- TMHC $44.32
- 52 Week High
- LNTH $126.89
- TMHC $74.69
- Technical
- Relative Strength Index (RSI)
- LNTH 39.89
- TMHC 50.52
- Support Level
- LNTH $75.00
- TMHC $68.01
- Resistance Level
- LNTH $118.21
- TMHC $69.92
- Average True Range (ATR)
- LNTH 5.48
- TMHC 1.97
- MACD
- LNTH -0.72
- TMHC -0.24
- Stochastic Oscillator
- LNTH 26.37
- TMHC 26.80
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About TMHC Taylor Morrison Home Corporation
Taylor Morrison Home Corp is an American residential construction company engaged in residential homebuilding and the development of lifestyle communities. It designs, builds and sells single and multi-family detached and attached homes in traditionally high growth markets for entry level, move-up, and resort lifestyle buyers. The company has four reportable segments: East, Central, West and Financial Services. The majority of the company's revenue is derived from its East Segment.